This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Andrew Price
Introduction
Andrew Price is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of immunology. He holds one patent that showcases his innovative approach to enhancing immune responses through advanced cellular technologies.
Latest Patents
Andrew Price's patent, titled "Chimeric antigen receptors and uses thereof," focuses on the development of immune effector cells, such as T cells and NK cells, that express a chimeric antigen receptor (CAR). This invention provides new compositions and methods for utilizing these engineered cells in therapeutic applications, potentially revolutionizing treatments for various diseases.
Career Highlights
Andrew Price is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis emphasizes the importance of innovative solutions in the pharmaceutical industry, particularly in the realm of cancer immunotherapy.
Collaborations
Andrew collaborates with talented professionals in his field, including Aida Abujoub and John Blankenship. Their combined expertise contributes to the advancement of research and development in immunotherapy.
Conclusion
Andrew Price's contributions to the field of immunology through his patent and work at Novartis AG highlight the importance of innovation in healthcare. His efforts pave the way for future advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile